前往化源商城

(D-ARG0,HYP3,D-PHE7,LEU8)-BRADYKININ

更新时间:2024-01-20 15:10:03

(D-ARG0,HYP3,D-PHE7,LEU8)-BRADYKININ结构式
(D-ARG0,HYP3,D-PHE7,LEU8)-BRADYKININ结构式
委托求购
常用名 (D-ARG0,HYP3,D-PHE7,LEU8)-BRADYKININ 英文名 (D-Arg0,Hyp3,D-Phe7,Leu8)-Bradykinin
CAS号 135701-67-6 分子量 1248.436
密度 1.5±0.1 g/cm3 沸点 N/A
分子式 C57H89N19O13 熔点 N/A
MSDS 美版 闪点 N/A

 (D-ARG0,HYP3,D-PHE7,LEU8)-BRADYKININ名称

中文名 (D-ARG0,HYP3,D-PHE7,LEU8)-BRADYKININ
英文名 [D-Arg0,Hyp3,D-Phe7,Leu8]-Bradykinin
英文别名 更多

 (D-ARG0,HYP3,D-PHE7,LEU8)-BRADYKININ物理化学性质

密度 1.5±0.1 g/cm3
分子式 C57H89N19O13
分子量 1248.436
精确质量 1247.688721
PSA 533.80000
LogP -1.49
折射率 1.681

 (D-ARG0,HYP3,D-PHE7,LEU8)-BRADYKININ安全信息

个人防护装备 Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
危险品运输编码 NONH for all modes of transport

 (D-ARG0,HYP3,D-PHE7,LEU8)-BRADYKININ文献5

更多文献
New highly potent bradykinin B2 receptor antagonists.

Agents Actions 34 , 138-141, (1991)

pA2 values of new B2 receptor antagonists ranging from 7.51 to 8.86 were measured on the rabbit jugular vein, while lower values were observed in the other preparations (for instance, the hamster urin...

Non-selectivity of new bradykinin antagonists for B1 receptors.

Life Sci. 51 , PL 125, (1992)

Two new B1 receptor antagonists, [Hyp3,Thi5,DTic7,Oic8]desArg9-BK and DArg[Hyp3,Thi5,DTic7,Oic8]desArg9-BK were tested in vitro on the rabbit jugular vein and the guinea pig ileum (preparations contai...

A new class of bradykinin antagonists: synthesis and in vitro activity of bissuccinimidoalkane peptide dimers.

J. Med. Chem. 35 , 1563, (1992)

A systematic study on the dimerization of the bradykinin (BK) antagonist D-Arg0-Arg1-Pro2-Hyp3-Gly4-Phe5-Ser6-D-Phe 7-Leu8-Arg9 has been performed. The first part of this study involved compounds wher...

 (D-ARG0,HYP3,D-PHE7,LEU8)-BRADYKININ英文别名

D-ARG-ARG-PRO-HYP-GLY-PHE-SER-D-PHE-LEU-ARG
L-Ornithine, N-(diaminomethylene)-D-ornithyl-N-(diaminomethylene)-L-ornithyl-L-prolyl-(4R)-4-hydroxy-L-prolylglycyl-L-phenylalanyl-L-seryl-D-phenylalanyl-L-leucyl-N-(diaminomethylene)-
Leu(8)]-bradykinin B2
D-Arg-L-Arg-L-Pro-L-t4Hyp-Gly-L-Phe-L-Ser-D-Phe-L-Leu-L-Arg-OH
D-ARG-[HYP3,D-PHE7,LEU8]-BRADYKININ
H-D-ARG-ARG-PRO-HYP-GLY-PHE-SER-D-PHE-LEU-ARG-OH
D-Arg(0)[Hyp(3),D-Phe(7),Leu(8)]-BK
D-Arg-L-Arg-L-Pro-4-Hydroxy-L-Pro-Gly-L-Phe-L-Ser-D-Phe-L-Leu-L-Arg-OH
Aaphgpspla
(D-ARG0,HYP3,D-PHE7,LEU8)-BRADYKININ
bradykinin,Arg-Hyp(3)-Phe(7)-Leu(8)
N-(Diaminomethylene)-D-ornithyl-N-(diaminomethylene)-L-ornithyl-L-prolyl-(4R)-4-hydroxy-L-prolylglycyl-L-phenylalanyl-L-seryl-D-phenylalanyl-L-leucyl-N-(diaminomethylene)-L-ornithine
D-Arg(0)[Hyp(3)